Raloxifene reduces procarboxypeptidase U, an antifibrinolytic marker. A 2-year randomised, placebo-controlled study in healthy early postmenopausal women. - Vogelvang, T; Leurs, J; van der Mooren, MJ (Menopause, 2004)